Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of lebrikizumab in uncontrolled asthma on inhaled corticosteroids and a second controller
2013-000175-33Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Lebrikizumab with Placebo (2 arms). Primary endpoint: Rate of asthma exacerbations during the 52-week placebo-controlled period. Started Aug 2013; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-000175-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000175-33.